Literature DB >> 22818342

Is intralesional verapamil effective therapy for Peyronie's disease?

Laurence A Levine1, Raymond A Costabile.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22818342     DOI： 10.1016/j.juro.2012.06.068

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

1.  A Critical Analysis of Reporting in Systematic Reviews and Meta-Analyses in the Peyronie's Disease Literature.

Authors:  Raevti Bole; Harrison Chase Gottlich; Matthew J Ziegelmann; Dillon Corrigan; Laurence A Levine; John P Mulhall; Petar Bajic
Journal:  J Sex Med       Date:  2022-02-15       Impact factor: 3.937

2.  Data vs Dogma in Peyronie's Disease.

Authors:  Ryan P Terlecki; Alison M Rasper
Journal:  Int Braz J Urol       Date:  2016 Nov-Dec       Impact factor: 1.541

Review 3.  Lengthening strategies for Peyronie's disease.

Authors:  Christopher D Gaffney; Matthew J Pagano; Aaron C Weinberg; Alex C Small; Franklin E Kuehas; Paulo H Egydio; Robert J Valenzuela
Journal:  Transl Androl Urol       Date:  2016-06

Review 4.  Nonsurgical Interventions for Peyronie's Disease: Update as of 2016.

Authors:  Gregory A Joice; Arthur L Burnett
Journal:  World J Mens Health       Date:  2016-08-23       Impact factor: 5.400
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.